Cancer Care Can’t Wait

It’s safe to get your mammogram
Rutgers Cancer Institute of New Jersey

New Brunswick, N.J., June 15, 2020 –During this stressful time, many people are worried about things in their lives that have been put on hold. For some women, this includes an annual mammogram.

Aside from skin cancer, breast cancer is the most commonly diagnosed cancer in women in the United States and will result in 42,000 deaths in the nation this year, according to the American Cancer Society.  The most effective screening tool for breast cancer is a mammogram, which uses low dose X-rays to create images of the breast. This method can find breast cancer before there are any signs or symptoms, and before the cancer grows larger or spreads to other parts of the body.

As we are past the peak of the pandemic and coronavirus cases are stabilizing in our communities, there is a need to start focusing on our overall health and wellness again while continuing to stay committed to preventing the spread of the virus. Safeguards have been put in place at Rutgers Cancer Institute of New Jersey and RWJBarnabas Health facilities so women can safely continue to get this potentially life-saving screening or any follow-up care that may be needed. 

Safety protocols include screening for COVID-19 symptoms upon entry, following strict social distancing measures, prohibiting most visitors, enhancing already rigorous cleaning and disinfecting practices, and mandating a mask or face covering for all patients and staff.

Identifying breast cancer early is an important tool, as we know that early detection improves a woman's overall prognosis. This test may save your life. Learn more at rwjbh.org/mammo or call 844-CANCERNJ (844-226-2376)

Deborah L. Toppmeyer, MD, is Chief Medical Officer and Director of the Stacy Goldstein Breast Cancer Center and LIFE Center at Rutgers Cancer Institute; and Professor of Medicine, Robert Wood Johnson Medical School.




Filters close

Showing results

110 of 2816
access_time Embargo lifts in 2 days
Embargo will expire: 6-Aug-2020 11:00 AM EDT Released to reporters: 5-Aug-2020 4:25 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 6-Aug-2020 11:00 AM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Newswise:Video Embedded uab-department-of-pathology-develops-strategy-to-support-guidesafe-entry-testing-process-more-than-200-000-samples
VIDEO
Released: 5-Aug-2020 4:10 PM EDT
UAB Department of Pathology develops strategy to support GuideSafe™ Entry Testing, process more than 200,000 samples
University of Alabama at Birmingham

This strategy will allow for ramping up testing capacity tenfold for the next 20-plus days leading up to the start of school.

Newswise: 239458_web.jpg
Released: 5-Aug-2020 2:50 PM EDT
New findings on enzymes with important role in SARS-CoV-2 infection
Uppsala University

Researchers at Uppsala University have described the presence, throughout the human body, of the enzyme ACE2.

Newswise: Button Project Lets Children See the Faces Behind the Masks
Released: 5-Aug-2020 2:50 PM EDT
Button Project Lets Children See the Faces Behind the Masks
Vanderbilt University Medical Center

When COVID-19 cases began rising in Nashville, masking became a regular part of life across Vanderbilt University Medical Center and Children’s Hospital as one of several public health safety measures to protect employees and patients from potential COVID-19 exposure. Children’s Hospital decided to get creative to ensure that the 1,700 children and families who visit the hospital and clinics each day can see that the same friendly faces they’ve always known still exist behind the masks.

Newswise: 239490_web.jpg
Released: 5-Aug-2020 1:45 PM EDT
Massey scientist suggests COVID-19 should be treated as an acute inflammatory disease
Virginia Commonwealth University (VCU)

The COVID-19 pandemic has had detrimental effects on global infrastructure sectors, including economic, political, health care, education and research systems, and there is still no definitive treatment strategy for the disease.

Newswise: Helping protect medical professionals
Released: 5-Aug-2020 1:05 PM EDT
Helping protect medical professionals
Sandia National Laboratories

A media comprised of a sandwich of materials, tested by Sandia National Laboratories, is being manufactured into N95-like respirators that could be used in local medical facilities. The project originated from the urgent need for personal protective equipment when the COVID-19 outbreak began.

Released: 5-Aug-2020 12:50 PM EDT
UCI scientists get ‘initial hit’ in developing drug to treat COVID-19
University of California, Irvine

Irvine, Calif., Aug. 5, 2020 – When the coronavirus pandemic hit, almost everyone at the University of California, Irvine – and colleges across the nation – had to abandon campus. But James Nowick, professor of chemistry, was not a part of that exodus. That’s because his lab, which designs and constructs chemical molecules, had the right equipment to help in the global push to find treatments for COVID-19.


Showing results

110 of 2816

close
1.42615